PTCT — PTC THERAPEUTICS INC

Ownership history in Brummer Multi-Strategy AB  ·  1 quarter on record

This page tracks every 13F SEC filing in which Brummer Multi-Strategy AB reported a position in PTC THERAPEUTICS INC (PTCT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
21.4% (2025 Q3)
Avg. % of fund
21.4%
First filed
2025 Q3
Last filed
2025 Q3
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 19,142 — — 21.40% $1.2M $61.37
% of Fund (quarterly)    PTCT price (monthly, adj. close)

Other funds also holding PTCT

As of 2025 Q4 — sorted by position size

Palo Alto Investors LP 3Y 7Y 9.56% RTW INVESTMENTS, LP 3Y 7Y 5.89% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 5.63% MPM BioImpact LLC 3Y 3.74% ARMISTICE CAPITAL, LLC 3Y 7Y 2.53% Parkman Healthcare Partners LLC 3Y 1.16% SECTOR GAMMA AS 3Y 7Y 1.07% Hood River Capital Management LLC 3Y 7Y 0.84% Abacus FCF Advisors LLC 3Y 7Y 0.75% Ikarian Capital, LLC 3Y 0.7%
← Back to Brummer Multi-Strategy AB Holdings